Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1967 2
1969 1
1970 4
1971 4
1972 4
1973 3
1974 10
1975 19
1976 22
1977 25
1978 35
1979 20
1980 43
1981 46
1982 41
1983 50
1984 64
1985 68
1986 65
1987 63
1988 75
1989 91
1990 94
1991 96
1992 111
1993 99
1994 104
1995 124
1996 120
1997 120
1998 115
1999 119
2000 128
2001 139
2002 154
2003 193
2004 207
2005 219
2006 264
2007 270
2008 372
2009 438
2010 563
2011 657
2012 801
2013 964
2014 1038
2015 1258
2016 1265
2017 1467
2018 1623
2019 1831
2020 2080
2021 2516
2022 2584
2023 2456
2024 1211

Text availability

Article attribute

Article type

Publication date

Search Results

23,815 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and classification of Goodpasture's disease (anti-GBM).
Hellmark T, Segelmark M. Hellmark T, et al. J Autoimmun. 2014 Feb-Mar;48-49:108-12. doi: 10.1016/j.jaut.2014.01.024. Epub 2014 Jan 21. J Autoimmun. 2014. PMID: 24456936 Free article. Review.
Goodpasture's disease or anti-glomerular basement membrane disease (anti-GBM-disease) is included among immune complex small vessel vasculitides. The definition of anti-GBM disease is a vasculitis affecting glomerular capillaries, pulmonary capillaries, or both, wit …
Goodpasture's disease or anti-glomerular basement membrane disease (anti-GBM-disease) is included among immune complex small vessel v …
Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review.
Fabian D, Guillermo Prieto Eibl MDP, Alnahhas I, Sebastian N, Giglio P, Puduvalli V, Gonzalez J, Palmer JD. Fabian D, et al. Cancers (Basel). 2019 Feb 2;11(2):174. doi: 10.3390/cancers11020174. Cancers (Basel). 2019. PMID: 30717372 Free PMC article. Review.
Glioblastoma (GBM) is the most common primary brain tumor. Despite aggressive treatment, GBM almost always recurs. ...In 2011, the first-generation tumor treating fields (TTF) device, known at the time as the NovoTTF-100A System (renamed Optune), was approved by the …
Glioblastoma (GBM) is the most common primary brain tumor. Despite aggressive treatment, GBM almost always recurs. ...In 2011, …
Using Light for Therapy of Glioblastoma Multiforme (GBM).
Vasilev A, Sofi R, Rahman R, Smith SJ, Teschemacher AG, Kasparov S. Vasilev A, et al. Brain Sci. 2020 Jan 31;10(2):75. doi: 10.3390/brainsci10020075. Brain Sci. 2020. PMID: 32024010 Free PMC article. Review.
: Glioblastoma multiforme (GBM) is the most malignant form of primary brain tumour with extremely poor prognosis. ...The key reason for that is that the surgical treatment fails to eradicate GBM cells completely, and adjacent parenchyma remains infiltrated by scatte …
: Glioblastoma multiforme (GBM) is the most malignant form of primary brain tumour with extremely poor prognosis. ...The key reason f …
Imaging of GBM in the Age of Molecular Markers and MRI Guided Adaptive Radiation Therapy.
Dajani S, Hill VB, Kalapurakal JA, Horbinski CM, Nesbit EG, Sachdev S, Yalamanchili A, Thomas TO. Dajani S, et al. J Clin Med. 2022 Oct 10;11(19):5961. doi: 10.3390/jcm11195961. J Clin Med. 2022. PMID: 36233828 Free PMC article. Review.
Glioblastoma (GBM) continues to be one of the most lethal malignancies and is almost always fatal. In this review article, the role of radiation therapy, systemic therapy, as well as the molecular basis of classifying GBM is described. Technological advances in the …
Glioblastoma (GBM) continues to be one of the most lethal malignancies and is almost always fatal. In this review article, the role o …
Glioblastoma: pathology, molecular mechanisms and markers.
Aldape K, Zadeh G, Mansouri S, Reifenberger G, von Deimling A. Aldape K, et al. Acta Neuropathol. 2015 Jun;129(6):829-48. doi: 10.1007/s00401-015-1432-1. Epub 2015 May 6. Acta Neuropathol. 2015. PMID: 25943888 Review.
Recent advances in genomic technology have led to a better understanding of key molecular alterations that underlie glioblastoma (GBM). The current WHO-based classification of GBM is mainly based on histologic features of the tumor, which frequently do not reflect t …
Recent advances in genomic technology have led to a better understanding of key molecular alterations that underlie glioblastoma (GBM …
Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery.
Nozhat Z, Heydarzadeh S, Shahriari-Khalaji M, Wang S, Iqbal MZ, Kong X. Nozhat Z, et al. Biomater Sci. 2023 Jun 13;11(12):4094-4131. doi: 10.1039/d2bm01996e. Biomater Sci. 2023. PMID: 37073998 Review.
Glioblastoma multiforme (GBM) has several distinctive characteristics linked to a poor early-stage prognosis. ...Herein, we review the recent developments in organic and inorganic biomaterial-based nanoparticles for GBM drug delivery. Firstly, we present a brief ove …
Glioblastoma multiforme (GBM) has several distinctive characteristics linked to a poor early-stage prognosis. ...Herein, we review th …
Atypical Anti-Glomerular Basement Membrane Disease.
Bharati J, Yang Y, Sharma P, Jhaveri KD. Bharati J, et al. Kidney Int Rep. 2023 Mar 21;8(6):1151-1161. doi: 10.1016/j.ekir.2023.03.010. eCollection 2023 Jun. Kidney Int Rep. 2023. PMID: 37284681 Free PMC article. Review.
Atypical anti-glomerular basement membrane (anti-GBM) disease is characterized by linear immunoglobulin G (IgG) deposition along the GBM without circulating IgG anti-GBM antibodies. Compared to classic anti-GBM disease, atypical anti-GBM disease …
Atypical anti-glomerular basement membrane (anti-GBM) disease is characterized by linear immunoglobulin G (IgG) deposition along the …
Delivering Glioblastoma a Kick-DGKalpha Inhibition as a Promising Therapeutic Strategy for GBM.
Purow B. Purow B. Cancers (Basel). 2022 Mar 1;14(5):1269. doi: 10.3390/cancers14051269. Cancers (Basel). 2022. PMID: 35267577 Free PMC article. Review.
A recent report indicates that DGKalpha deficiency increases responsiveness of macrophages, indicating that DGKalpha inhibition could also have the potential to boost macrophage and microglia activity against GBM-which could be a particularly promising approach given the h …
A recent report indicates that DGKalpha deficiency increases responsiveness of macrophages, indicating that DGKalpha inhibition could also h …
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers.
Delello Di Filippo L, Hofstätter Azambuja J, Paes Dutra JA, Tavares Luiz M, Lobato Duarte J, Nicoleti LR, Olalla Saad ST, Chorilli M. Delello Di Filippo L, et al. Eur J Pharm Biopharm. 2021 Nov;168:76-89. doi: 10.1016/j.ejpb.2021.08.011. Epub 2021 Aug 28. Eur J Pharm Biopharm. 2021. PMID: 34461214 Review.
Glioblastoma multiforme (GBM) is the most common primary brain cancer. GBM has aggressive development, and the pharmacological treatment remains a challenge due to GBM anatomical characteristics' (the blood-brain barrier and tumor microenvironment) and the in …
Glioblastoma multiforme (GBM) is the most common primary brain cancer. GBM has aggressive development, and the pharmacological …
23,815 results
You have reached the last available page of results. Please see the User Guide for more information.